Navigation Links
Bayer's Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
Date:12/8/2011

WAYNE, N.J., Dec. 8, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced that at a joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA), the majority of Advisory Committee members voted (15 to 11) that the benefits of drospirenone-containing combination oral contraceptives (COCs) in the prevention of pregnancy outweigh the potential risks.  The Committee members also voted (21 to 5) that the current labels for Bayer's drospirenone-containing combination oral contraceptives do not adequately reflect the risk benefit profile for these products and should be revised to include additional information from available studies. 

Recommendations from the Committees will be considered by the FDA in making its final decision. 

"We thank the Committee members for their efforts and participation in the discussion on the benefit-risk profile for drospirenone-containing combination oral contraceptives," said Pamela A. Cyrus, M.D., Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals. 

Bayer has consistently worked with the FDA and other regulatory authorities around the world as new data have become available regarding drospirenone-containing COCs, and has worked with the agencies to make label updates as appropriate.  Bayer will continue to do so.

About Bayer HealthCare Pharmaceuticals, Inc.

Bayer HealthCare Pharmaceuticals, Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals provides product
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS
2. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
3. Takeda Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin
4. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
5. New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
6. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
7. FDA Approves Combination Therapy Juvisync
8. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
9. Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
10. New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
11. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... 2014 As health officials across the Midwest warn against ... in Michigan will offer free diagnostic ... Meijer pharmacists to administer tests and, in some cases, fill ... participating in the study. The Grand ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
(Date:7/11/2014)... -- Polio is history in much of the world, ... Pakistan. Giving vaccinated children an extra dose of inactivated ... the highly infectious disease, a new study suggests. ... as early as a year after vaccination. Vaccinated children ... the spread of the disease, according to background information ...
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... is now providing worldwide clients with the most fashionable ... comes to buying summer wedding dresses online, ladies become ... of beautiful wedding gowns. Recently, the company has launched ... , The company’s current promotion is specially launched ... newest fashion trends. The top experts from AngelWeddingDress want ...
(Date:7/11/2014)... 11, 2014 American Farmer is proud ... Tuesday, July 15, 2014, at 8:30 am ET. , ... proprietary products, which are designed and formulated for use ... learn how these products help the crop realize its ... it is grown. , The show also features UniSouth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Alliance Labs ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , In this episode, Innovations will explore ... 100mg docusate sodium in polyethylene glycol base designed to ... how the formulation functions as a hyperosmotic laxative by ...
Breaking Medicine News(10 mins):Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... Concentra ("Concentra" or the,"Company"), a national leader ... unique combination of medical services and general wellness ... Oregon, is known for its,safe, reliable air transportation ... was searching for an on-site health program that,matched ...
... revenues of $77.8 million, up 11% from,the prior year - Earnings per ... over the second quarter of 2007 - Operating cash flow of ... ... life,sDHA(TM), COLUMBIA, Md., Sept. 5 Martek Biosciences,Corporation (Nasdaq: MATK ...
... BOHEMIA, N.Y., Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of ... follows (amounts,are rounded):, ... ... FOR THE MONTH OF AUGUST ...
... PARIS, Sept. 5 Sanofi-aventis announced the,publication of ... which,demonstrated that dronedarone (MULTAQ(TM)), a new anti-arrhythmic agent ... placebo in,maintaining sinus rhythm while not promoting pro-arrhythmias ... atrial fibrillation,(AF) and atrial flutter (AFL). AF, ...
... trauma patients, study finds , , WEDNESDAY, Sept. 5 (HealthDay ... does not reduce the need for blood transfusions among ... trauma patients. , The drug, epoetin alfa (brand ... because of potentially dangerous side effects. , "Unlike prior ...
... Club and Spa will soon have an East Valley location, ... DMB Executives, another first class Village Health Club and Spa ... Chandler,Arizona. As of July 31st, the land at the corner ... club design has been approved. The,purchase of the 7.3 acres ...
Cached Medicine News:Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Martek Announces Third Quarter 2007 Financial Results 2Health News:Martek Announces Third Quarter 2007 Financial Results 3Health News:Martek Announces Third Quarter 2007 Financial Results 4Health News:Martek Announces Third Quarter 2007 Financial Results 5Health News:Martek Announces Third Quarter 2007 Financial Results 6Health News:Martek Announces Third Quarter 2007 Financial Results 7Health News:Martek Announces Third Quarter 2007 Financial Results 8Health News:Martek Announces Third Quarter 2007 Financial Results 9Health News:Martek Announces Third Quarter 2007 Financial Results 10Health News:Martek Announces Third Quarter 2007 Financial Results 11Health News:Martek Announces Third Quarter 2007 Financial Results 12Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 2Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 4Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 5Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 2Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 3Health News:Ocotillo in Chandler Will Have a Village 2
Inquire...
... Designed for the elegant and ... Avenue collection includes ophthalmic and ... in a variety of shapes ... many face shapes and complexions. ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: